Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions

Lian Narunsky-Haziza, Gregory D. Sepich-Poore, Ilana Livyatan, Omer Asraf, Cameron Martino, Deborah Nejman, Nancy Gavert, Jason E. Stajich, Guy Amit, Antonio González, Stephen Wandro, Gili Perry, Ruthie Ariel, Arnon Meltser, Justin P. Shaffer, Qiyun Zhu, Nora Balint-Lahat, Iris Barshack, Maya Dadiani, Einav N. Gal-YamSandip Pravin Patel, Amir Bashan, Austin D. Swafford, Yitzhak Pilpel, Rob Knight*, Ravid Straussman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

282 Scopus citations

Abstract

Cancer-microbe associations have been explored for centuries, but cancer-associated fungi have rarely been examined. Here, we comprehensively characterize the cancer mycobiome within 17,401 patient tissue, blood, and plasma samples across 35 cancer types in four independent cohorts. We report fungal DNA and cells at low abundances across many major human cancers, with differences in community compositions that differ among cancer types, even when accounting for technical background. Fungal histological staining of tissue microarrays supported intratumoral presence and frequent spatial association with cancer cells and macrophages. Comparing intratumoral fungal communities with matched bacteriomes and immunomes revealed co-occurring bi-domain ecologies, often with permissive, rather than competitive, microenvironments and distinct immune responses. Clinically focused assessments suggested prognostic and diagnostic capacities of the tissue and plasma mycobiomes, even in stage I cancers, and synergistic predictive performance with bacteriomes.

Original languageEnglish
Pages (from-to)3789-3806.e17
JournalCell
Volume185
Issue number20
DOIs
StatePublished - 29 Sep 2022

Funding

FundersFunder number
Dr. Dvora and Haim Teitelbaum Endowment Fund
Fabrikant-Morse Families Research Fund for Humanity
Israel Cancer Research Fund and City of HopeHHSN261201500003I, HHSN261201400008C, 17X146, 5K12GM068524-17
Merck EMD Serono284860
Moross Integrated Cancer Center
Swiss Society Institute for Cancer Prevention Research
National Institutes of HealthDP1AT010885
National Institute on Drug AbuseP50DA026306
National Cancer InstituteF30 CA243480, U24 CA248454, R01 CA255206
University of California
Horizon 2020 Framework Programme
European Research Council
Weizmann Institute of Science
United States-Israel Binational Science Foundation2013332
Israel Science Foundation2927/21
Horizon 2020818086
Rising Tide Foundation

    Keywords

    • biomarkers
    • cancer
    • fungi
    • liquid biopsy
    • metagenomics
    • metatranscriptomics
    • microbial interactions
    • tumor microbiome
    • tumor mycobiome

    Fingerprint

    Dive into the research topics of 'Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions'. Together they form a unique fingerprint.

    Cite this